COMMUNIQUÉS West-GlobeNewswire

TZOA Launches Canada’s First All-in-One Smart Home Air Filtration Solution, HAVEN

31/07/2019 - 15:00

Capable of improving residential air quality by upwards of 90 percent, HAVEN will be available for purchase across Western Canada over the next three months in time for forest fire season air quality concerns VANCOUVER [...]

Afrezza® Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3

31/07/2019 - 15:00

MannKind announces the opening of enrollment for this final cohort before moving to phase 3 in this pediatric clinical trial WESTLAKE VILLAGE, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD [...]

Ritter Pharmaceuticals Hosts Conference Call on August 7, 2019 to Highlight Recent Lactose Intolerance Market Research Findings

31/07/2019 - 15:00

Daniel P. Lundberg, Consultant to Ritter Pharmaceuticals and former Senior VP of Marketing at Salix Pharmaceuticals to address market opportunity for Phase 3, lactose intolerance drug candidate RP-G28 LOS ANGELES, July [...]

Teladoc Health Names Health Tech Veteran David Sides as Chief Operating Officer

31/07/2019 - 14:35

PURCHASE, NY, July 31, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announced that it has named David Sides as chief operating officer. A former corporate CEO and a longtime [...]

Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors

31/07/2019 - 14:30

SAN DIEGO, July 31, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced initiation of a Phase 1 [...]

SeaSpine Announces Launch of Mariner® Outrigger® Revision System

31/07/2019 - 14:30

CARLSBAD, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Atlas Nanotech Opens First Revenue Stream

31/07/2019 - 14:30

Multipurpose contract signed with Gem Labs GUADALAJARA, Mexico, July 31, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.), DBA Atlas Nanotech, today memorialized an agreement with Laboratorios Gem S.A. de C [...]

Menlo Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference

31/07/2019 - 14:30

REDWOOD CITY, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]

ChemoCentryx to Hold Second Quarter 2019 Financial Results Conference Call on Monday, August 5, 2019

31/07/2019 - 14:30

MOUNTAIN VIEW, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2019 financial results will be released after market close on Monday, August [...]

Stryker declares a $0.52 per share quarterly dividend

31/07/2019 - 14:15

Kalamazoo, Michigan, July 31, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on October 31, 2019 to shareholders of record [...]

SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA® (pembrolizumab) Program with Dosing of First Patient in Phase 1/2 Basket Study

31/07/2019 - 14:15

- Study is Being Conducted with Merck Under a Clinical Trial Collaboration and Supply Agreement - - Trial to Enroll Patients with Ovarian, Colorectal, Triple Negative Breast, and Small Cell Lung Cancers and Acute [...]

Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada

31/07/2019 - 14:10

Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada DUBLIN and LUGANO, July 31, 2019 -- Endo International plc (NASDAQ: ENDP), and Helsinn, a Swiss pharmaceutical group [...]

Catalyst Pharmaceuticals to Hold Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 8th, 2019

31/07/2019 - 14:03

CORAL GABLES, Fla., July 31, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference

31/07/2019 - 14:01

MENLO PARK, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]

Align Technology Announces $200 Million Accelerated Stock Repurchase Program

31/07/2019 - 14:00

Joe Hogan, president and CEO, intends to personally purchase $1.0 million of Align’s common stock SAN JOSE, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced that it has entered [...]

Jounce Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 7, 2019

31/07/2019 - 14:00

CAMBRIDGE, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

Intercept to Announce Second Quarter 2019 Financial Results on August 7, 2019

31/07/2019 - 14:00

NEW YORK, July 31, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

Pluristem and U.S. Department of Defense Present Positive Data from Studies Testing PLX-R18 as a Prophylactic Treatment for Acute Radiation Syndrome

31/07/2019 - 14:00

PLX-R18 demonstrated significant increase in survival rates and recovery of the three blood lineages Data is jointly presented at the 2019 Radiation Injury Treatment Network (RITN) Workshop HAIFA, Israel, July 31, 2019 [...]

Zynerba Pharmaceuticals to Present at Two Upcoming Conferences

31/07/2019 - 14:00

DEVON, Pa., July 31, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]